BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jou E, Rajdev L. Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol 2016; 22(20): 4812-4823 [PMID: 27239108 DOI: 10.3748/wjg.v22.i20.4812]
URL: https://www.wjgnet.com/1007-9327/full/v22/i20/4812.htm
Number Citing Articles
1
María L Bacigalupo, Pablo Carabias, María F Troncoso. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progressionWorld Journal of Gastroenterology 2017; 23(29): 5266-5281 doi: 10.3748/wjg.v23.i29.5266
2
Zhihong Huang, Ping Wei. Compound Kushen Injection for gastric cancerMedicine 2019; 98(45): e17927 doi: 10.1097/MD.0000000000017927
3
Hao Wang, Ying‑Hua Luo, Gui‑Nan Shen, Xian‑Ji Piao, Wan‑Ting Xu, Yi Zhang, Jia‑Ru Wang, Yu‑Chao Feng, Jin‑Qian Li, Yu Zhang, Tong Zhang, Shi‑Nong Wang, Hui Xue, Hong‑Xing Wang, Chang‑Yuan Wang, Cheng‑Hao Jin. Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathwaysMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10500
4
Yubin Feng, Maomao Wu, Shuang Hu, Xiaoqing Peng, Feihu Chen. LncRNA DDX11-AS1: a novel oncogene in human cancerHuman Cell 2020; 33(4): 946 doi: 10.1007/s13577-020-00409-8
5
Ozgur Oktem. Fertility Preservation2021; : 116 doi: 10.1017/9781108784368.012
6
Yu Liang, Limin Zhang. Influence of reminiscence therapy on mental health and quality of life in elderly patients with unresectable, metastatic gastrointestinal cancerBrazilian Journal of Medical and Biological Research 2024; 57 doi: 10.1590/1414-431x2024e13344
7
Jianling Xia, Hongqiang Wang, Shi Li, Qinghui Wu, Li Sun, Hongxiang Huang, Ming Zeng. Ion channels or aquaporins as novel molecular targets in gastric cancerMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0622-y
8
Padmaraju Vasudevaraju, Malla Rama Rao. Immunotherapy for Gastrointestinal MalignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 79 doi: 10.1007/978-981-15-6487-1_6
9
Giulia Accordino, Sara Lettieri, Chandra Bortolotto, Silvia Benvenuti, Anna Gallotti, Elisabetta Gattoni, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Patrizia Morbini, Andrea Lancia, Giulia Maria Stella. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary PerspectiveCancers 2020; 12(8): 2105 doi: 10.3390/cancers12082105
10
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster, Susanne Müller. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinibOncotarget 2020; 11(5): 535 doi: 10.18632/oncotarget.27462
11
Xuefeng Yang, Mingda Wang, Bohao Lin, Dongjie Yao, Jin Li, Xianchun Tang, Sanhua Li, Yun Liu, Rui Xie, Shouyang Yu. miR-487a promotes progression of gastric cancer by targeting TIA1Biochimie 2018; 154: 119 doi: 10.1016/j.biochi.2018.08.006
12
Akira Okita, Hiroo Imai, Masahiro Takahashi, Hidekazu Takahashi, Sho Umegaki, Yoshifumi Kawamura, Sakura Hiraide, Kota Ouchi, Yuko Sato, Yoshinari Okada, Keigo Komine, Ken Saijo, Shin Takahashi, Masanobu Takahashi, Hidekazu Shirota, Hisatsugu Ohori, Makio Gamoh, Chikashi Ishioka. Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisThe Tohoku Journal of Experimental Medicine 2018; 245(2): 123 doi: 10.1620/tjem.245.123
13
Zishu Wang, Kaikai Yu, Yudong Hu, Fang Su, Zhenyuan Gao, Ting Hu, Yang Yang, Xiangliao Cao, Feng Qian. Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cellsBiochemical Pharmacology 2020; 173: 113673 doi: 10.1016/j.bcp.2019.113673
14
Luo Li, Keshan Wang, Zhenguo Liu, Yajuan Lü, Congcong Wang, Xuefei Yi, Jianping Guo. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathwayWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02609-y
15
Shoichiro Mukai, Naohide Oue, Takashi Oshima, Takeharu Imai, Yohei Sekino, Ririno Honma, Naoya Sakamoto, Kazuhiro Sentani, Hiroki Kuniyasu, Hiroyuki Egi, Kazuaki Tanabe, Kazuhiro Yoshida, Hideki Ohdan, Wataru Yasui. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancerThe Journal of Pathology 2017; 243(1): 100 doi: 10.1002/path.4931
16
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancerWorld Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
17
Markus Moehler, Min-Hee Ryu, Mikhail Dvorkin, Keun-Wook Lee, Hasan Ş Coşkun, Rachel Wong, Hyun C Chung, Artem Poltoratsky, Akihito Tsuji, Chia Jui Yen, Alina S Muntean, Samuel Le Sourd, Gina M Vaccaro, Lindsay Overton, Narikazu Boku, Zev A Wainberg, Manish Patel, Maitreyi Sharma, Huiling Xiong, Ilaria Conti, Julien Taieb, Yung-Jue Bang. Maintenance Avelumab Versus Continuation of First-Line Chemotherapy in Gastric Cancer: JAVELIN Gastric 100 Study DesignFuture Oncology 2019; 15(6): 567 doi: 10.2217/fon-2018-0668
18
Yunfei Zhang, Fengchang Huang, Ning Xu, Jin Wang, Dan Li, Liang Yin. Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancerClinics 2021; 76: e2081 doi: 10.6061/clinics/2021/e2081
19
Helem Ferreira Ribeiro, Carla de Castro Sant’ Anna, Valdenira de Jesus Oliveira Kato, Rafael Maia de Sousa Brasil, Amanda Braga Bona, Danielle Feio da Costa, Isamu Komatsu Lima, Paulo Cardoso Soares, Ana Paula Araújo Guimarães, Paulo Pimentel de Assumpção, Rommel Rodriguez Burbano. CDC25B Inhibition by Menadione: A Potential New Therapeutical ApproachAnti-Cancer Agents in Medicinal Chemistry 2022; 22(17): 2927 doi: 10.2174/1871520622666220418131935
20
Batoul Farran, Susanne Müller, Raquel C Montenegro. Gastric cancer management: Kinases as a target therapyClinical and Experimental Pharmacology and Physiology 2017; 44(6): 613 doi: 10.1111/1440-1681.12743
21
Jicai Wang, Zhilei Su, Shounan Lu, Wen Fu, Zhifa Liu, Xingming Jiang, Sheng Tai. LncRNA HOXA-AS2 and its molecular mechanisms in human cancerClinica Chimica Acta 2018; 485: 229 doi: 10.1016/j.cca.2018.07.004
22
Julien Taieb, Markus Moehler, Narikazu Boku, Jaffer A. Ajani, Eduardo Yañez Ruiz, Min-Hee Ryu, Silke Guenther, Vikram Chand, Yung-Jue Bang. Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectivesCancer Treatment Reviews 2018; 66: 104 doi: 10.1016/j.ctrv.2018.04.004
23
Subbroto Kumar Saha, Polash Kumar Biswas, Minchan Gil, Ssang-Goo Cho. High Expression of TTYH3 Is Related to Poor Clinical Outcomes in Human Gastric CancerJournal of Clinical Medicine 2019; 8(11): 1762 doi: 10.3390/jcm8111762
24
Naohide Oue, Kazuhiro Sentani, Naoya Sakamoto, Naohiro Uraoka, Wataru Yasui. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cellsInternational Journal of Clinical Oncology 2019; 24(7): 771 doi: 10.1007/s10147-019-01443-9
25
Tianfang Xia, Zhenguo Pan, Jie Zhang. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR‐4720‐3p/TJP1 axisCancer Medicine 2020; 9(12): 4299 doi: 10.1002/cam4.3057
26
Yifan Lian, Zeling Cai, Huangbo Gong, Songling Xue, Dongdong Wu, Keming Wang. HOTTIP: a critical oncogenic long non-coding RNA in human cancersMolecular BioSystems 2016; 12(11): 3247 doi: 10.1039/C6MB00475J
27
Jiao Guo, Chun‐Dong Zhang, Jia‐Xiang An, Yun‐Yun Xiao, Shuai Shao, Nuo‐Ming Zhou, Dong‐Qiu Dai. Expression of miR‐634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cellsCancer Medicine 2018; 7(3): 776 doi: 10.1002/cam4.1204
28
Didem Tunalı, Sule Yildiz Oğuz, Ugur Selek, Emre Balik, Senol Tonyali, Sertac Yazici, Özgür Öktem. Textbook of Gastrointestinal Oncology2019; : 633 doi: 10.1007/978-3-030-18890-0_35
29
Yanfeng Li, Guanyu Zhu, Yan Ma, Hongyan Qu. Retracted: lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1Journal of Cellular Biochemistry 2019; 120(12): 19457 doi: 10.1002/jcb.29239
30
Yao Wang, Yuanyuan Guo, Tianchi Zhuang, Ting Xu, Minghui Ji. SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 AxisFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.936037
31
Hoda Fazaeli, Azar Sheikholeslami, Fatemeh Ghasemian, Elaheh Amini, Mohsen Sheykhhasan. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A ReviewCurrent Molecular Medicine 2023; 23(7): 606 doi: 10.2174/1566524022666220509122505
32
Bihong Xu, Chunyu Huang, Xianzi Yang, Xiangzhao Li, Liang Li, Yanqing Ding. Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancerOncology Letters 2018;  doi: 10.3892/ol.2018.7992
33
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal typeOncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
34
Xiao-ying Zhang, Pei-ying Zhang. Gastric cancer: somatic genetics as a guide to therapyJournal of Medical Genetics 2017; 54(5): 305 doi: 10.1136/jmedgenet-2016-104171
35
George Gourzoulidis, Maria Koulentaki, Anna Koumarianou, Epaminondas Samadas, Nikolaos Androulakis, Spyridon Xynogalos, Pavlos Papakotoulas, Ioannis Boukovinas, Michalis Karamouzis, John Souglakos, Vasiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba. Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in GreeceExpert Review of Pharmacoeconomics & Outcomes Research 2022; 22(2): 259 doi: 10.1080/14737167.2021.1921576
36
Lin Shen, Jun Guo, Qingyuan Zhang, Hongming Pan, Ying Yuan, Yuxian Bai, Tianshu Liu, Qing Zhou, Jun Zhao, Yongqian Shu, Xiaoming Huang, Siyang Wang, Jie Wang, Aiping Zhou, Dingwei Ye, Ting Sun, Yujuan Gao, Silu Yang, Zoubai Wang, Jian Li, Yi-Long Wu. Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 studyJournal for ImmunoTherapy of Cancer 2020; 8(1): e000437 doi: 10.1136/jitc-2019-000437
37
Olga Sokolova, Michael Naumann. NF‐κB Signaling in Gastric CancerToxins 2017; 9(4): 119 doi: 10.3390/toxins9040119
38
Kizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, Kazuaki Takabe, Toshifumi Wakai. Hypermutation and microsatellite instability in gastrointestinal cancersOncotarget 2017; 8(67): 112103 doi: 10.18632/oncotarget.22783